Dr. Reddy's Laboratories
118 hedge funds and large institutions have $817M invested in Dr. Reddy's Laboratories in 2017 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 32 increasing their positions, 46 reducing their positions, and 13 closing their positions.
0% more capital invested
Capital invested by funds: $814M → $817M (+$3.04M)
0% more funds holding
Funds holding: 118 → 118 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
2.96% less ownership
Funds ownership: 68.55% → 65.59% (-3%)
30% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 46
73% less call options, than puts
Call options by funds: $357K | Put options by funds: $1.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$27.9M |
| 2 |
MIP
Mondrian Investment Partners
London,
United Kingdom
|
+$12.8M |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$5.12M |
| 4 |
H
Hexavest
Montreal,
Quebec, Canada
|
+$4.09M |
| 5 |
Aviva
London,
United Kingdom
|
+$3.04M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$13.6M |
| 2 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$13.3M |
| 3 |
HSBC Holdings
London,
United Kingdom
|
-$11.7M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$9.45M |
| 5 |
JP Morgan Chase
New York
|
-$7.29M |
RDY Hedge Fund Activity: Q4 2017 in Review
118 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q4 2017, worth a combined $817M — up 0.37% from $814M a quarter earlier.
Fund positioning in RDY was balanced in Q4 2017: 13 funds opened new positions, 13 closed out, 32 added to existing stakes and 46 trimmed.
The largest buyer was Royal Bank of Canada, adding an estimated $27.9M. The largest seller was UBS Group, cutting an estimated $13.6M.
- 118 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $817M of Dr. Reddy's Laboratories stock for Q4 2017, up 0.37% quarter-over-quarter.
- 13 funds opened new Dr. Reddy's Laboratories positions in Q4 2017 and 13 closed out, a net change of 0 holders.
- The largest Dr. Reddy's Laboratories buyer in Q4 2017 was Royal Bank of Canada, an estimated $27.9M added.
- The largest Dr. Reddy's Laboratories seller in Q4 2017 was UBS Group, an estimated $13.6M sold.
Based on aggregated 13F filings for Q4 2017.